TFBS Bioscience, Inc. (6939) Stock Statistics & Valuation Metrics
Total Valuation
TFBS Bioscience, Inc. has a market cap or net worth of TWD 642.22M. The enterprise value is ―.
- Market Cap
- TWD 642.22M
- Enterprise Value
- ―
Share Statistics
TFBS Bioscience, Inc. has 35,384,163 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 35,384,163
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
TFBS Bioscience, Inc.’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -5.61%.
- Return on Equity (ROE)
- -0.06
- Return on Assets (ROA)
- -0.05
- Return on Invested Capital (ROIC)
- -5.61%
- Return on Capital Employed (ROCE)
- -0.06
- Revenue Per Employee
- 2.27M
- Profits Per Employee
- -876.69K
- Employee Count
- 85
- Asset Turnover
- 0.13
- Inventory Turnover
- 11.24
Valuation Ratios
The current PE Ratio of TFBS Bioscience, Inc. is -9.73. TFBS Bioscience, Inc.’s PEG ratio is -0.10.
- PE Ratio
- -9.73
- PS Ratio
- 3.30
- PB Ratio
- 0.57
- Price to FCF
- -5.76
- Price to Operating Cash Flow
- 320.82
- PEG Ratio
- -0.10
Income Statement
In the last 12 months, TFBS Bioscience, Inc. had revenue of 193.14M and earned -74.52M in profits. Earnings per share was -2.13.
- Revenue
- 193.14M
- Gross Profit
- 36.82M
- Operating Income
- -78.00M
- Pretax Income
- -73.94M
- Net Income
- -74.52M
- EBITDA
- -19.25M
- Earnings Per Share (EPS)
- -2.13
Cash Flow
In the last 12 months, operating cash flow was 2.02M and capital expenditures -114.45M, giving a free cash flow of -112.43M billion.
- Operating Cash Flow
- 2.02M
- Free Cash Flow
- -112.43M
- Free Cash Flow per Share
- -3.18
Dividends & Yields
TFBS Bioscience, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -17.46%
- Earnings Yield
- -10.24%
Stock Price Statistics
- Beta
- 0.33
- 52-Week Price Change
- -23.74%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 40.07
- Average Volume (3m)
- 30.60K
Financial Position
TFBS Bioscience, Inc. as a current ratio of 2.61, with Debt / Equity ratio of 19.33%
- Current Ratio
- 2.61
- Quick Ratio
- 2.54
- Debt to Market Cap
- 0.13
- Net Debt to EBITDA
- 4.27
- Interest Coverage Ratio
- -27.74
Taxes
In the past 12 months, TFBS Bioscience, Inc. has paid 577.00K in taxes.
- Income Tax
- 577.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
TFBS Bioscience, Inc. EV to EBITDA ratio is -33.63, with an EV/FCF ratio of -5.20.
- EV to Sales
- 2.98
- EV to EBITDA
- -33.63
- EV to Free Cash Flow
- -5.20
- EV to Operating Cash Flow
- 289.81
Balance Sheet
TFBS Bioscience, Inc. has TWD 394.62M in cash and marketable securities with TWD 209.74M in debt, giving a net cash position of TWD 184.88M billion.
- Cash & Marketable Securities
- TWD 394.62M
- Total Debt
- TWD 209.74M
- Net Cash
- TWD 184.88M
- Net Cash Per Share
- TWD 5.22
- Tangible Book Value Per Share
- TWD 31.55
Margins
Gross margin is 6.57%, with operating margin of -35.37%, and net profit margin of -33.59%.
- Gross Margin
- 6.57%
- Operating Margin
- -35.37%
- Pretax Margin
- -34.01%
- Net Profit Margin
- -33.59%
- EBITDA Margin
- -8.86%
- EBIT Margin
- -35.37%
Analyst Forecast
The average price target for TFBS Bioscience, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 11.65%
- EPS Growth Forecast
- -10.17%
